SinoVeda Canada Inc. and Exzell Pharma Inc. recently announced the signing of an exclusive license agreement to commercialize Effecti-Cal in Canada, the U.S., Australia and New Zealand. The agreement includes upfront and milestone payments, as well as royalties on sales. The specific terms of the transaction were not disclosed.
Effecti-Cal is approved by Health Canada as a Natural Health Product to support the development and maintenance of healthy bones and teeth. Effecti-Cal is a source of highly soluble and absorbable calcium, magnesium, and zinc that can be taken with or without food. Effecti-Cal is well tolerated and has fewer side effects. Gastrointestinal side effects such as constipation, gas, bloating, and abdominal pain are commonly caused by other calcium supplements, but not with Effecti-Cal.
Full Article Here: www.pharmaceuticalonline.com
The post SinoVeda And Markham Based Exzell Pharma Sign Commercialization Agreement For Effecti-Cal appeared first on Toronto Area's Tech Hub.